EDU 33 - Evolving Paradigms in Axillary Nodal Management: Precision Medicine Refining Regional Breast Cancer Care
MODERATOR(S)
Peter Chen, MD, FASTRO, FACR - Oakland University William Beaumont School of Medicine
session DESCRIPTION
There is ever more scientific data to allow for de-escalation of treatment to the axillary regional nodes in early-stage to regionally advanced non-metastatic breast cancer through seminal studies such as SOUND, INSEMA, and NSABP B-51. All have shown that in select patients less treatment directed to the axillary region may suffice without detrimental results on disease control outcomes, with consequent sparing of treatment-related morbidity of normal surrounding structures/tissues/function.
learning objectives
- Describe in early-stage breast cancer that non-invasive diagnostic assessment of the ipsilateral axilla may allow for safe omission of sentinel nodal mapping in select patients.
- Describe and discuss how neoadjuvant therapy has changed the role of both radiation and surgical oncology approaches to treatment of the axillary regional nodes in patients achieving a pathological complete response to upfront systemic therapy.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:02pm ETSpeaker: Peter Chen, MD, FASTRO, FACR - Oakland University William Beaumont School of Medicine, Bloomfield Hills
-
05:02pm - 05:17pm ETSpeaker: Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University , Boca Raton
-
05:17pm - 05:32pm ET
Clinicopathological and Biology-based Decision Aids for Regional Nodal Irradiation in N1 non-distant metastatic Breast Cancer
Speaker: Atif Khan, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
05:32pm - 05:47pm ETSpeaker: Terry Mamounas, MD - Northeast Ohio Medical University, Rootstown
-
05:47pm - 06:00pm ETSpeaker: Peter Chen, MD, FASTRO, FACR - Oakland University William Beaumont School of Medicine, Bloomfield Hills